The report follows an FDA announcement on Friday indicating its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Oct. 15 will discuss the administration of the J&J COVID-19 booster shot for individuals 18 years and older, a day after similar discussions are planned for the Moderna COVID-19 booster shot among people ages 18 and older. The J&J booster shot shows 71% immunity against the coronavirus. Awesome!
Photo Credit: Jazmin Quaynor
コメント